Neogenomics Inc (NEO) Clearly Signals Buy-Into the Stock: Don’t ignore the signals

With 1.07 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.02 million shares. The 52-week range on NEO shows that it touched its highest point at $19.11 and its lowest point at $9.59 during that stretch. It currently has a 1-year price target of $18.67. Beta for the stock currently stands at 1.28.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NEO was down-trending over the past week, with a drop of -14.23%, but this was down by -35.27% over a month. Three-month performance dropped to -44.24% while six-month performance fell -41.33%. The stock lost -38.43% in the past year, while it has lost -41.87% so far this year. A look at the trailing 12-month EPS for NEO yields -0.62 with Next year EPS estimates of 0.35. For the next quarter, that number is -0.01. This implies an EPS growth rate of 60.61% for this year and 98.98% for next year.

Float and Shares Shorts:

At present, 128.15 million NEO shares are outstanding with a float of 126.92 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NEO since 8 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.12006 being high and $0.08731822 being low. For NEO, this leads to a yearly average estimate of $0.098233. Based on analyst estimates, the high estimate for the next quarter is $0.07 and the low estimate is $0.03. The average estimate for the next quarter is thus $0.05.

Summary of Insider Activity:

Insiders traded NEO stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.